Phibro Animal Health (PAHC) Income towards Parent Company (2012 - 2026)

Phibro Animal Health's Income towards Parent Company history runs 15 years deep, the most recent figure standing at $24.0 million for Q1 2026.

• In Q1 2026, Income towards Parent Company rose 15.06% year-over-year to $24.0 million; the TTM figure through Mar 2026 stood at $25.8 million (up 1426.75% YoY), while the FY2025 annual figure was -$21.2 million, up 32.38% from the prior year.
• Income towards Parent Company was $24.0 million for Q1 2026 at Phibro Animal Health, down from $27.5 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $27.5 million in Q4 2025 to a low of -$52.2 million in Q2 2025.
• Historically, Income towards Parent Company has averaged $1.4 million across 5 years, with a median of $7.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Income towards Parent Company sank 1747.96% in 2022, then soared 762.14% in 2025.
• A 5-year view of Income towards Parent Company shows it stood at $7.2 million in 2022, then tumbled by 82.33% to $1.3 million in 2023, then jumped by 150.0% to $3.2 million in 2024, then soared by 762.14% to $27.5 million in 2025, then fell by 12.51% to $24.0 million in 2026.
• The last three Income towards Parent Company figures came in at $24.0 million (Q1 2026), $27.5 million (Q4 2025), and $26.5 million (Q3 2025), per Business Quant data.